Interaction between the human NK receptors and their ligands

Critical Reviews in Immunology

Volumn 20, Issue 3, 2000, Pages 223-244

  Vales Gomez, Mar ^a   Reyburn, Hugh ^b   Strominger, Jack L ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CD94 NKG2; Immunoglobulin superfamily receptors (KIR); Immunoglobulin like transcripts (ILTs); Natural killer (NK) cells

Indexed keywords

CD94 ANTIGEN; CHEMOKINE; CYTOKINE; HLA ANTIGEN CLASS 1;

ALLOIMMUNITY; CHROMOSOME 19; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; LIGAND BINDING; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD94; HLA ANTIGENS; HUMANS; ISOANTIGENS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, IMMUNOLOGIC;

EID: 0033840346     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (155)

1. How to recognize a foreign submarine
2. In search of the 'missing self': MHC molecules and NK recognition
3. Skin graft rejection by beta 2-microglobulin-deficient mice
4. - lymphocytes to express their functional program(s)
5. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition
6. Natural killer lines and clones with apparent antigen specificity
7. + natural killer cells requires the expression of an autosomic recessive gene on target cells
8. Evidence of a natural killer (NK) cell repertoire for (allo)antigen recognition: Definition of five distinct NK-determined allospecificities in human
9. Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B
10. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene
11. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C
12. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2)
13. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells
14. Proliferation of alloreactive human natural killer cells independent of specific allogeneic stimulation
15. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing
16. Class I-induced resistance to natural killing: Identification of nonpermissive residues in HLA-A2
17. Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type
18. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80
19. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones
20. HLA-E. A novel HLA class I gene expressed in resting T lymphocytes
21. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule
22. Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element
23. Maternal/fetal interactions: The role of the MHC class I molecule HLA-G
24. Immunology: Keeping mother at bay
25. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells
26. - decidual and peripheral blood leukocytes
27. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells
28. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells
29. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1
30. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells
31. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex
32. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
33. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
34. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
35. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
36. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient
37. The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1b
38. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C
39. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
40. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
41. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells
42. Arousal and inhibition of human NK cells
43. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56)
44. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
45. Structure and function of leukocyte integrins
46. Biology of natural killer cells
47. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells
48. The natural killer gene complex: A genetic basis for understanding natural killer cell function and innate immunity
49. + T lymphocytes. II. Modulation of natural killer cell cytotoxicity by anti-Kp43 monoclonal antibody
50. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
51. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor
52. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
53. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily
54. Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors
55. Isolation and characterization of NK cell or NK/T cell-specific cDNA clones
56. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
57. Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes
58. An activating immunoreceptor complex formed by NKG2D and DAP10
59. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
60. Association of DAP12 with activating CD94/NKG2C NK cell receptors
61. + T lymphocytes. I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody
62. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
63. Mouse NKR-P1. A family of genes selectively coexpressed in adherent lymphokine-activated killer cells
64. Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1
65. Molecular cloning of the NK1,1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules
66. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes
67. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity
68. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity
69. Structure of the gene coding for the human early lymphocyte activation antigen CD69: A C-type lectin receptor evolutionarily related with the gene families of natural killer cell-specific receptors
70. LAG-3, a novel lymphocyte activation gene closely related to CD4
71. Identification of a human member of the Ly-49 multigene family
72. The human Ly-49L gene
73. The killer cell inhibitory receptor genomic region on human chromosome 19q13.4
74. + natural killer cells. Role in cell activation and regulation of cytolytic function
75. p58 Molecules as putative receptors for major-histocompatibility complex (MHC) class I molecules in human natural killer cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities
76. Cloning of immunoglobulin superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
77. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intra-cellular domains
78. Molecular cloning of NKB1: A natural killer cell receptor for HLA-B allotypes
79. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
80. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype
81. NK cell receptor of the KIR family with two Ig domains, but highest homology to KIR receptors with three Ig domains
82. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM)
83. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases
84. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1
85. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor
86. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C
87. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C
88. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells
89. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
90. Inhibition of antigen-induced T-cell response and antibody-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
91. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
92. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
93. Alternatively spliced forms of human killer inhibitory receptors
94. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin like domains and is expressed as a 140-kd disulphide linked dimer
95. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors
96. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2
97. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I
98. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
99. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
100. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
101. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
102. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
103. Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex
104. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
105. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
106. p46, A novel natural killer cell-specific surface molecule that mediates cell activation
107. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
108. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility-restricted tumour cell lysis
109. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
110. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells
111. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes
112. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules
113. The binding site of NK receptors on HLA-C molecules
114. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells
115. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extra-cellular domains but differ in their transmembrane and intracytoplasmic portions
116. T-cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function
117. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes
118. + lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function
119. Enhancement of class II-restricted T-cell responses by costimulatory NK receptors for class I MHC proteins
120. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and functional transfer
121. Human natural killer cell inhibitory receptors bind to HLA class I molecules
122. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule
123. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
124. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
125. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
126. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
127. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
128. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells
129. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells
130. NKB1: An NK cell receptor involved in the recognition of polymorphic HLA-B molecules
131. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
132. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: Requirement for all three p70 immunoglobulin domains
133. Peptide-induced modulation of target cell sensitivity to natural killing
134. Peptide specificity in the recognition of MHC class I by natural killer cell clones
135. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells
136. Self and viral peptides can initiate lysis by autologous natural killer cells
137. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity
138. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis
139. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors
140. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells
141. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors
142. Functional ambivalence of the Kp43 (CD94) NK cell associated surface antigen
143. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
144. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene
145. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles
146. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes
147. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies
148. Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation
149. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
150. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
151. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
152. Multiple receptors for HLA-G on human natural killer cells
153. RASMOL: Biomolecular graphics for all
154. Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site